Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Other Conditions
Vol. 2, Issue 2, 2015
July 15, 2015 EDT
Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR
Mike Durkin
,
Jacqueline Pesa
,
Jessica Lopatto
,
Rachel Halpern
,
Damon Van Voorhis
,
Stephanie Korrer
,
oxycodone cr
tapentadol er
resource use
health care costs
chronic pain
Copyright Logo
ccby-4.0
•
https://doi.org/10.36469/9905
Photo by
Simone van der Koelen
on
Unsplash
JHEOR
1.
Durkin M, Pesa J, Lopatto J, Halpern R, Van Voorhis D, Korrer S. Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR.
JHEOR
. 2015;2(2):221-232.
doi:10.36469/9905
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats